Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults
Executive Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is a specialized, advanced endoscopic procedure utilized for the radiographic visualization and therapeutic management of pancreaticobiliary disorders. While historically diagnostic, the role of ERCP has shifted significantly toward therapeutic intervention due to the emergence of highly accurate, non-invasive diagnostic modalities such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound (EUS).
ERCP is technically demanding, requiring specialized training and experience. It carries a higher risk profile compared to standard endoscopic procedures, with a distinct set of serious complications, including post-ERCP pancreatitis, bleeding, infection, and perforation. Effective management involves rigorous patient selection, comprehensive pre-procedure preparation (including medication management and antibiotic prophylaxis), and strict adherence to post-procedural monitoring protocols. Quality indicators, such as cannulation success rates exceeding 90%, serve as benchmarks for procedural proficiency. Financially, ERCP represents a significant area of medical liability, commanding the highest mean malpractice payment amount per claim among endoscopic procedures.
Clinical Indications and Patient Selection
The primary role of ERCP is therapeutic. Because ERCP is associated with significant risks, it is generally reserved for cases where intervention is required.
Primary Indications
Choledocholithiasis: Removal of bile duct stones.
Acute Cholangitis: Relieving biliary obstruction, especially in cases associated with sepsis.
Malignant Biliary Obstruction: Drainage for conditions such as pancreatic cancer or hilar cholangiocarcinoma.
Post-Surgical Complications: Management of bile leaks or biliary strictures following surgery (e.g., cholecystectomy or liver transplantation).
Pancreatitis Management: Addressing complications of acute or chronic pancreatitis, including pancreatic duct strictures or stones.
Primary Sclerosing Cholangitis: Treatment of extrahepatic biliary strictures.
Sphincter of Oddi Dysfunction: Endoscopic therapy for select patients.
Contraindications and Risk Assessment
ERCP is contraindicated when the procedural risks outweigh the potential benefits.
Relative Contraindications: Inability to tolerate monitored anesthesia care (MAC) or general anesthesia, untreated hemostatic disorders, and gastrointestinal luminal obstructions proximal to the target area.
Exceptions: Patients with acute severe cholangitis and cardiorespiratory dysfunction may still undergo ERCP due to the high mortality risk associated with untreated biliary sepsis.
Pre-Procedural Protocols
Laboratory Testing and Medication Adjustment
Most patients require a baseline evaluation including a complete blood count (CBC), prothrombin time (PT)/international normalized ratio (INR), liver biochemical tests, and pancreatic enzymes. Management of antiplatelet and anticoagulant therapy must be individualized and coordinated with prescribing specialists.
Anesthesia and Positioning
Anesthesia: Procedures are typically performed under MAC or general anesthesia.
Positioning:
Prone: The standard position for ERCP.
Supine: Utilized for patients with recent abdominal wounds, external drains, or to facilitate airway management. While technically more challenging, success rates are comparable to the prone position.
Left Lateral Decubitus: Occasionally used for patient comfort (e.g., pregnancy or limited cervical movement), but less reliable for fluoroscopic interpretation of ductal anatomy.
Infection Control and Prophylaxis
Antibiotic prophylaxis is determined by the patient's specific risk factors for infection.
Procedural Methodology
Mechanism of Action
A side-viewing upper endoscope is guided into the duodenum. Instruments are passed through the ampulla of Vater into the biliary or pancreatic ducts. A contrast medium is then injected to opacify the ducts for radiographic visualization.
Gas Insufflation
Carbon dioxide (CO2) is the preferred agent for insufflating the gastrointestinal lumen.
Benefits: CO2 is rapidly absorbed by the mucosa and eliminated via the lungs, unlike ambient air.
Outcomes: Meta-analyses indicate that CO2 use significantly reduces post-procedure abdominal pain at one, three, and six hours and is associated with a lower overall risk of complications (OR 0.59). There is no evidence of increased hypercapnia risk in most studies.
Adverse Events and Risk Mitigation
ERCP is associated with serious complications that must be recognized early to initiate treatment.
Pancreatitis: The most frequent serious complication. It can result from mechanical injury, hydrostatic injury from contrast, or guidewire manipulation.
Bleeding: Often associated with biliary or pancreatic sphincterotomy (the use of high-frequency current to cut the sphincter).
Infection: Linked to incomplete drainage of the biliary system, infected pancreatic fluid collections, or contaminated equipment.
Perforation: May occur in the esophagus, stomach, or small intestine. Sphincterotomy-related perforations are typically retroperitoneal.
Rare Events: Gas embolism, pneumothorax, and pneumoperitoneum.
Post-Procedural Care
Monitoring and Diet
Observation: Outpatients are monitored for two to six hours to detect early complications like pancreatitis. Some clinicians prefer overnight hospitalization.
Dietary Progression:
High-Risk Patients: Clear liquids for the first 24 hours.
Low-Risk Patients: Clear liquids for four to six hours (or the remainder of the day if the procedure was late), followed by solid food if tolerated.
Quality Indicators and Competency benchmarks
To ensure safety and procedural efficacy, specialty societies (such as the ASGE) have established performance targets:
Appropriate Indication Documentation: >90%
Ductal Cannulation Success (Native Papilla): >90%
Common Bile Duct Stone Extraction (<1 cm): ≥90%
Successful Stent Insertion (Nonhilar Obstruction): ≥90%
Safety Tracking: Mandatory tracking of post-ERCP pancreatitis rates.
Specialized Populations and Liability
Special Populations
Pregnancy: ERCP is performed when necessary to manage gallstone complications, with specific techniques used to minimize fetal and maternal risk.
Surgically Altered Anatomy: Patients with Roux-en-Y or Billroth II reconstructions require innovative endoscopic approaches because a standard duodenoscope often cannot reach the ampulla.
